Technical Analysis for KALA - Kala Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 14.63 3.25% 0.46
KALA closed up 3.25 percent on Thursday, March 23, 2023, on 16 percent of normal volume.
Earnings due: Mar 27
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish 3.25%
200 DMA Support Bullish 3.25%
Inside Day Range Contraction 3.25%
Wide Bands Range Expansion 3.25%
50 DMA Resistance Bearish -3.43%
Crossed Above 20 DMA Bullish -3.43%
Crossed Above 200 DMA Bullish -3.43%
Wide Bands Range Expansion -3.43%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 12 hours ago
20 DMA Resistance about 12 hours ago
10 DMA Resistance about 12 hours ago
Up 5% about 13 hours ago
Up 3% about 13 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Organ Systems Pain Eye Inflammation Ophthalmic Macular Degeneration Tyrosine Kinase Retina Wet Age Related Macular Degeneration Glucocorticoids Retinal Disease Receptor Tyrosine Kinase Blepharitis Post Surgical Ocular Inflammation

Is KALA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 93.5
52 Week Low 3.55
Average Volume 938,031
200-Day Moving Average 14.04
50-Day Moving Average 15.97
20-Day Moving Average 15.18
10-Day Moving Average 15.25
Average True Range 2.53
RSI 48.45
ADX 24.31
+DI 28.26
-DI 18.38
Chandelier Exit (Long, 3 ATRs) 16.40
Chandelier Exit (Short, 3 ATRs) 16.87
Upper Bollinger Bands 22.45
Lower Bollinger Band 7.92
Percent B (%b) 0.46
BandWidth 95.73
MACD Line -0.19
MACD Signal Line 0.04
MACD Histogram -0.2252
Fundamentals Value
Market Cap 820.38 Million
Num Shares 56.1 Million
EPS -2.87
Price-to-Earnings (P/E) Ratio -5.10
Price-to-Sales 64.50
Price-to-Book 3.86
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.66
Resistance 3 (R3) 16.71 16.07 16.33
Resistance 2 (R2) 16.07 15.55 16.05 16.21
Resistance 1 (R1) 15.35 15.23 15.71 15.31 16.10
Pivot Point 14.72 14.72 14.90 14.69 14.72
Support 1 (S1) 13.99 14.20 14.36 13.95 13.16
Support 2 (S2) 13.36 13.88 13.34 13.05
Support 3 (S3) 12.64 13.36 12.93
Support 4 (S4) 12.60